Climacteric Syndrome Clinical Trial
Official title:
The Effects of Luo-Bu-Fu-Ke-Bi-RI Pill
NCT number | NCT05846698 |
Other study ID # | 2021-375 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 1, 2017 |
Est. completion date | December 31, 2021 |
Verified date | August 2023 |
Source | First Affiliated Hospital of Chongqing Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To investigate the effect of LBFKBRP on climacteric syndrome in women and explore its therapeutic mechanism.
Status | Completed |
Enrollment | 276 |
Est. completion date | December 31, 2021 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 41 Years to 60 Years |
Eligibility | Clinical diagnosis of climacteric syndrome |
Country | Name | City | State |
---|---|---|---|
China | The First Affiliated Hospital of Chongqing Medical University | Chongqing | Chongqing |
Lead Sponsor | Collaborator |
---|---|
Guoqing Zhou |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sex hormone | 3 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Not yet recruiting |
NCT06419972 -
Multimodal Program for Climacteric Women
|
N/A | |
Completed |
NCT01275807 -
Effectiveness and Safety of Acupuncture for Climacteric Syndrome in Patients With Breast Cancer
|
Phase 4 | |
Recruiting |
NCT06136208 -
Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women
|
N/A | |
Withdrawn |
NCT01695616 -
Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms
|
Phase 3 | |
Completed |
NCT03118908 -
Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome
|
N/A |